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A R T I C L E I N F O
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A B S T R A C T
Polybrominated diphenyl ethers (PBDEs) and hexabromocyclododecane (HBCDD) were used intensively as ﬂame
retardants, worldwide. They have been detected in human serum samples and PBDEs have been found to be
elevated in young children. Commercial Penta- and Octa-PBDE mixtures were banned in Australia in 2005, while
HBCDD was banned worldwide in 2013. We investigated PBDE and HBCDD concentrations in serum collected
from young children. We also investigated temporal trends in PBDE concentration 10 years after their Australian
ban.
Surplus human blood serum samples were collected through a pathology clinic (n=800), in 2014/15,
stratiﬁed by age (0–6, 6–12, 12–18, 18–24, 24–30, 30–36, 36–42, 42–48, 48–54 and 54–60months) and sex and
pooled for analysis of PBDEs (BDEs−28,−47,−99,−100,−153,−154,−183) and HBCDD. In 2014/15, the
geometric mean concentration of the sum of all PBDEs measured (ΣPBDEs) was 4.5 ng/g lipid (median: 4.6 ng/g
lipid, range: 0.88–26 ng/g lipid). A positive association between BDE-47 concentration and age was observed
(R=0.41, p=0.008), however there were no trends between other PBDE congeners or HBCDD and age. There
were no signiﬁcant diﬀerences between genders for PBDEs (t-test, p=0.802) or HBCDD (t-test, p=0.740).The
highest concentrations observed were in pools from the females 30–36month (26 ng/g lipid) and Males
6–12month (21 ng/g lipid) categories. BDEs −47 and −99 were the predominant congeners with a combined
average contribution of 75% of ΣPBDEs.
PBDEs showed a signiﬁcant reduction in children aged 0–4 years over an eight year period. In 2014/15, the
mean (range) concentration of BDE-47 is 2.8 (0.23 to 11) ng/g lipid compared to pools in 2006/07 at 19 (3–55)
ng/g lipid (p < 0.0001) and for BDE-153 is 0.73 (< 0.1=−2.9) ng/g lipid compared to pools in 2006/07 at
4.7 (2−10) ng/g lipid (p < 0.0001). HBCDD concentrations were lower than PBDEs with a mean concentration
of 0.45 ng/g lipid. There were no temporal trends observed for HBCDD when compared to samples collected in
2012. The dominant stereoisomer was α-HBCDD (mean= 0.38 ng/g lipid) with an average contribution of 65%
towards ΣHBCDD.
Levels of PBDEs in young Australian children have signiﬁcantly decreased since the bans of commercial
Penta- and Octa-BDE in 2005. There has been no observed decrease in HBCDD levels in Australian children since
its ban in 2012.
1. Introduction
Brominated ﬂame retardants (BFRs) such as polybrominated di-
phenyl ethers (PBDEs) and hexabromocyclododecane (HBCDD) have
been used as a cost eﬀective and eﬃcient means of reducing
ﬂammability and therefore reducing risk of harm to humans from ﬁres.
There are three commercial PBDE formulations - Penta-, Octa- and
DecaBDE. The main PBDE applications include electrical and electronic
equipment (EEE - such as TVs, PCs and small domestic appliances)
(European Commission, 2011), soft furnishings (e.g. sofas, mattresses,
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T
pillows and curtains) (United Nations Environment Programme
(UNEP), 2010) and in polyurethane foam (PUF) seat ﬁllings used in
automobiles (European Chemicals Bureau, 2000). The primary use of
HBCDD is to ﬂame retard expanded and extruded polystyrene (EPS/
XPS) used in building insulation foam (European Chemicals Agency,
2009).
Both PBDEs and HBCDD are lipophilic and resistant to metabolism
allowing them to bioaccumulate in the liver and other fatty tissues.
They have long half-lives in humans of approximately 1.8–6.5 years and
0.2 years for PBDEs and HBCDD, respectively (Geyer et al., 2004), and
have been associated with adverse health eﬀects. PBDEs are thought to
disrupt levels of sex hormones, including luteinising hormone and fol-
licle stimulating hormone in men (Meeker et al., 2009), cause toxic
eﬀects in other organs including liver, kidneys and thyroid gland;
neurodevelopmental deﬁcits including inhibited foetal and infant de-
velopment; and various cancers (Costa et al., 2008). Data on human
health eﬀects of HBCDD exposure is limited, however recent studies
have demonstrated that HBCDD displays oestrogenic properties
(Dorosh et al., 2011) and can damage dopamine neurons with potential
for neurological and endocrine disruption (Genskow et al., 2015). There
is also evidence for reduced birthweight and signiﬁcant adverse neu-
rodevelopment, including impaired motor skills and increased anxiety
levels in rodent models (Maurice et al., 2015). Concerns over persis-
tence and toxicity led to importation bans commercial Penta- and Octa-
BDE into Australia in 2005 (Toms et al., 2009), prior to global bans of
all three commercial PBDE formulations and HBCDD under the UNEP
Stockholm Convention of Persistent Organic Pollutants (Stockholm
Convention, 2009; Health and Environment Alliance, 2013; Chemical
Watch, 2017). Penta and OctaBDEs have never been manufactured in
Australia (NICNAS, 2007). These bans do not apply to PBDEs in-
corporated into products made in other countries and imported into
Australia. Exposure to PBDEs continues with an assessment of PBDEs in
microenvironments in Australia in 2015 ﬁnding sumPBDE (BDEs-28,
47, 99, 100, 153, 154, 183 and 209) concentrations in dust of 2.1 μg/g
dust (He et al., 2018).
PBDEs and HBCDDs have been detected in various environmental
compartments resulting in direct human exposure through food
(Fernandes et al., 2004), dust (Toms et al., 2015), sediment (Drage
et al., 2015) and breast milk (Toms et al., 2012). Despite a cessation in
new usage of these BFRs, products treated with PBDEs and HBCDDs will
remain in use for some time with the potential to provide environ-
mental and human exposure sources. Biomonitoring in Australia re-
vealed unexpectedly high concentrations of PBDEs compared to “tra-
ditional” persistent organic pollutants (POPs) such as dioxins and
polychlorinated biphenyls with highest concentrations in young age
groups at 4 times that of adults (Toms et al., 2008). These high con-
centrations raised concerns that young children may be more vulner-
able to possible adverse health eﬀects from exposure to higher con-
centrations of PBDEs (Grandjean and Landrigan, 2014). More recently,
studies of adults in other countries have suggested that PBDE levels
have reached a plateau in the US (Hurley et al., 2017; Parry et al.,
2018)) while elsewhere some studies suggest a continued decrease (Ma
et al., 2017; Zhang et al., 2017). Data on HBCDD in the Australian
population is more limited, with only two previous studies (Toms et al.,
2012; Drage et al., 2017). Both studies demonstrated high variability in
HBCDD concentrations, with no obvious temporal trends. Neither study
focussed on samples from children.
The aim of this study was to investigate PBDE and HBCDD con-
centrations in infants and children in Australia using 10 age groups
under the age of 5 years to investigate speciﬁc small age group trends as
ﬁrst identiﬁed with pools from 2006/07 where peak PBDE concentra-
tions occurred in children 2–5 years (Toms et al., 2009). Temporal
trends were assessed by comparing the PBDE concentrations of this
study to the previous data obtained from the same age groups in 2006/
07 as well as pooled data collected every two years from 2004/05 to
2014/15.
2. Materials and methods
2.1. Chemicals & reagents
High purity solvents (HPLC grade), sulfuric acid (analytical grade),
sodium sulfate, silica gel (high purity grade, 60 Å pore size) and Florisil
(60–100 mesh particle size) were purchased from Sigma Aldrich
(Germany). Hydromatrix was purchased from Agilent (Santa Clara, CA,
USA). 13C12-labelled standards for HBCDDs (α-, β- and γ- isomers),
PBDEs (−28, −47, −99, −153, −154, −183 and −77) and 13C12-
TBBPA, native HBCDDs (α-, β- and γ- isomers) and PBDEs (BDEs −28,
−47, −99, −100, −153, −154 and− 183) were purchased from
Wellington Laboratories (Guelph, ON, Canada).
2.2. Sample collection & preparation
Sample collection occurred in 2014 and 2015 from South East
Queensland, Australia. Human blood samples were obtained in a de-
identiﬁed manner from surplus pathology samples through a commu-
nity pathology clinic (Sullivan Nicolaides Pathology). The data pro-
vided was date of birth, date of collection, gender and postcode. The
serum samples were pooled by gender (males and females) and from 10
age groups (0–6, 6–12, 12–18, 18–24, 24–30, 30–36, 36–42, 42–48,
48–54 and 54–60months). The total number of samples was 800 with
20 samples in each pool and one replicate pool per strata, that is, for
females 0–6months there were two pools of 20 samples each and so on
for each age group and gender. While these samples cannot be assumed
to represent the entire population of Australia, this sampling metho-
dology has been used for almost two decades to assess age, gender and
temporal trends for many environmental pollutants in Australia (Toms
et al., 2014; Heﬀernan et al., 2016; Thomas et al., 2017). There are
limitations to pooling as outlined by Heﬀernan et al. (2014) such as an
inability to detect the lowest and highest exposed in the population but
the advantages include ease of logistics and trend analysis. Ethics ap-
proval for this study was granted by The University of Queensland
Medical Research Ethics Committee and Queensland University of
Technology.
2.3. Lipid analysis of serum samples
Aliquots (300 μL) of each sample were sent to Sullivan Nicolaides
Pathology for analysis of total cholesterol (TC) and triglycerides (TG).
Total lipid (TL) concentration (mg/dL) was calculated using Eq. (1)
(Phillips et al., 1989).
= + +TL 2.27. TC TG 62.3 (1)
2.4. Sample extraction and clean-up
Samples underwent a combined extraction and clean-up using
pressurised liquid extraction (PLE) on an ASE 350 (Dionex, Sunnyvale,
CA, USA). 5 g of each serum pool was weighed into a 15mL falcon tube.
10 μL of an internal standard mixture (containing 100 pg/μL of 13C12
BDEs −28, −47, −99, −100, −153, −154, −183 and 13C12- α-, β-
and γ-HBCDD in methanol). Samples were vortexed for 2min and
transferred into 100mL Dionium™ ASE cells, pre-packed from the
bottom upwards with 2 x glass ﬁbre ﬁlters (GFF), 5 g silica, 2 g hy-
dromatrix, 1 x (GFF) 12 g sulfuric acid (44%) impregnated silica, 1 x
GFF, 5 g ﬂorisil, 30 g anhydrous sodium sulfate, 10 g diatomaceous
earth. Cells were loaded onto the ASE 350 and extracted using
hexane:DCM (3:2, v/v ratio) at 90 °C and 1500 psi. The heating time
was 5min, with a 4min static time, purge time 120 s and ﬂush volume
50%. Three static cycles were required to achieve maximum recovery of
all target compounds. Clean extracts were transferred to round-bot-
tomed ﬂasks and concentrated to 1–2mL in a rotavap (Buchi). Samples
were transferred to 5mL disposable glass tubes and concentrated to
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near-dryness at 40 °C under a gentle stream of nitrogen. The sample was
reconstituted in 50 μL toluene containing 1 ng of 13C12-BDE-77 as a
recovery standard and transferred to a 200 μL inserted autsosampler
vial. After analysis of PBDEs via GC/HRMS, extracts were solvent ex-
changed into 50 μL methanol containing 1 ng of 13C12-TBBPA as a re-
covery standard for analysis of HBCDDs via LC-MS/MS.
2.5. Instrumental analysis
Samples were analysed for PBDEs (BDEs −28, −47, −99, −100,
−153,−154,−183) via a Thermo 1310 gas chromatograph coupled to
a DFS Magnetic Sector high resolution mass spectrometer (GC-HRMS).
The HRMS was operated in electron impact-multiple ion detection (EI-
MID) mode, and resolution was set to≥10,000 (10% valley deﬁnition).
Full method parameters have been published previously (Wang et al.,
2017).
HBCDD (α-, β- and γ-) was measured in serum extracts using an AB/
Sciex API 5500Q mass spectrometer (AB/Sciex, Concord, Ontario,
Canada) coupled to a Shimadzu Nexera HPLC system (Shimadzu Corp.,
Kyoto, Japan). The mass spectrometer (MS) was operated in multiple
reaction monitoring (MRM) mode using negative electrospray ionisa-
tion (ESI). Separation was achieved using a Kinetex XB C18,
50×2.0mm 1.7 μm column (Phenomenex, Torrance CA) using a mo-
bile phase gradient of 85% methanol, ramping up to 100% methanol
over 6min and then holding for 4min at a ﬂow rate of 0.3 mL/min. Full
LC-MS/MS details including MRM parameters have been published
previously (Drage et al., 2017).
2.6. Quality assurance/quality control
To avoid cross-contamination of samples during extraction and
clean-up, a rinsing cycle (using the same solvent combination) was
programmed before and after each diﬀerent extraction. Furthermore,
all pre-packed cells underwent a pre-extraction under the same para-
meters, prior to the loading of samples, to reduce any interferences or
potential blank contamination from the in-cell components during
analyses.
A blank sample consisting of 5mL bovine serum was extracted with
every batch of samples. All target analytes were below the limits of
detection in blank samples. Therefore no correction for blank con-
centrations occurred. The method was validated by repeated analysis
(n=6) of a pooled in-house QC sample. This consisted of pooled
human serum which had been previously characterised and found to
contain between< 1.0 pg/mL (BDEs −100 and −154) and 10 pg/mL
(BDEs −47 and −153). Three 5mL aliquots were spiked with 1 ng of
each target analyte. The concentrations were then measured and the
recoveries of target analytes calculated. Average recoveries for PBDEs
ranged from 90% (BDE-153) to 116% (BDE-100). Average recoveries
for HBCDDs were 91% (α-HBCDD), 90% (β-HBCDD) and 87% (γ-
HBCDD). The relative standard deviation (RSD) was< 15% for all
target compounds.
For all target compounds method detection limits (MDLs) were
calculated based on a chromatogram signal to noise of 10:1. MDLs for
PBDEs were 0.1 ng/g lipid for BDEs −28, −47, −99 and −100;
0.12 ng/g lipid for BDEs−154 and−153; and 0.15 ng/g lipid for BDE-
183. The MDL for all HBCDD isomers was 0.1 ng/g lipid.
2.7. Statistical analysis
All statistical tests were carried out using Microsoft Excel 2010 and
Prism Graphpad. For the purpose of averages and statistical calcula-
tions, all samples found below the method detection limit (MDL) were
assigned a value of MDL/√2. As the data was log-normally distributed,
associations between age and contaminant concentration were assessed
using a Pearson correlation on log-transformed data while signiﬁcant
diﬀerences between genders were tested using a t-test on log-trans-
formed data. To assess temporal trends, signiﬁcant diﬀerences between
novel and historical datasets were tested using a Mann-Whitney U test.
Conﬁdence intervals were set to 95%.
BDEs – 28, −100, −154 and −183 were detected in<50% of
pools and are therefore discussed brieﬂy. However, a table of ∑PBDEs
and ∑HBCDD concentrations for each individual pool is available in SI
Table S1. Due to the low detection frequency of other congeners this
paper will primarily discuss the individual concentrations for BDEs
−47, −99 and −153 rather than the sum of all congeners.
3. Results and discussion
The average concentration and detection frequencies of all com-
pounds measured in this study are presented in Table 1. PBDEs were
detected in measureable concentrations in all pools (n=40) for chil-
dren aged 0–5 years. The geometric mean concentration of the sum of
all PBDEs measured (ΣPBDEs) was 4.5 ng/g lipid (median: 4.6 ng/g
lipid, range: 0.88–26 ng/g lipid). BDEs −47 and −99 were the pre-
dominant congeners with a combined average contribution of 75% of
ΣPBDEs. BDE-47 was detected in all samples with a median con-
centration of 2.7 ng/g lipid (range: 0.23–11 ng/g lipid). This was fol-
lowed by BDE-99, which was detected in 80% of samples
(median= 0.85 ng/g lipid, range:< 0.1–24 ng/g lipid) and BDE-153,
which was detected in 75% of samples and made up 15% of ΣPBDEs
(median= 0.58 ng/g lipid, range:< 0.12–2.9 ng/g lipid). The re-
maining average ΣPBDE content was made up of BDE-28 (4.4%), BDE-
183 (2.3%) and BDE-100 (1.8%). This is consistent with congener
proﬁles seen in, amongst others, Australia (Toms et al., 2009), USA
(Stapleton et al., 2012; Eskenazi et al., 2011), Nicaragua (Athanasiadou
et al., 2008), Spain (Gari and Grimalt (2013), Pakistan (Ali et al., 2003)
and Mexico (Pérez-Maldonado et al., 2009), and typical of exposure to
products treated with the Penta-BDE commercial formulation. As the
majority of PBDEs measured in this study were detected in 50% or
fewer samples, only BDEs−47,−99 and,−153 are discussed from this
point on (as mentioned in Section 2.7).
HBCDD was detected in 90% of samples with a geometric mean of
0.45 ng/g lipid (range:< 0.1–1.9 ng/g lipid). The dominant stereo-
isomer was α-HBCDD (median=0.32 ng/g lipid, range:< 0.1–1.3 ng/
g lipid) with an average contribution of 65% towards ΣHBCDD. This
was followed by γ-HBCDD (median= 0.15 ng/g lipid, range:<
0.1–1.4 ng/g lipid), which contributed 35% towards ΣHBCDD. β-
HBCDD was not detected in any of the 40 pools. The concentrations of
HBCDD in children's serum were generally lower than those of PBDEs.
This is likely to be because HBCDD is generally found in lower
Table 1
Concentrations (ng/g lipid) of PBDEs and HBCDDs in serum from Australian children 0–4 years old in 2014/15.
Chemical BDE 28 BDE 47 BDE 100 BDE 99 BDE 154 BDE 153 BDE 183 ΣPBDEs α-HBCDD β-HBCDD γ-HBCDD ΣHBCDD
Detection frequency (%) 50 100 30 80 7.5 75 28 N/A 85 0 75 N/A
Mean 0.22 2.8 0.22 1.9 0.11 0.73 0.18 5.9 0.38 < 0.1 0.25 0.62
Geometric mean 0.13 2.1 0.11 0.66 0.08 0.36 0.10 4.5 0.30 < 0.1 0.17 0.45
Median 0.09 2.7 < 0.1 0.85 <0.12 0.58 < 0.15 4.61 0.32 < 0.1 0.15 0.48
Min <0.1 0.23 < 0.1 < 0.1 <0.12 < 0.12 < 0.15 0.88 < 0.1 < 0.1 < 0.1 < 0.1
Max 1.4 11 2.3 24 1.2 2.9 1.1 26 1.3 < 0.1 1.4 1.90
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concentrations than PBDEs in environmental samples as it is typically
added to products at 0.7–2% by weight (European Commission, 2011),
while products treated with PBDEs have been treated in concentrations
of up to 25% by weight of the various commercial mixtures (European
Commission, 2011; UNEP, 2010). Moreover,> 95% of HBCDD use has
been application to cavity wall insulation, while PBDEs are more
commonly used in electronics and furniture, and are therefore more
likely to volatilise from their products through more regular use (Drage
Fig. 1. Concentrations of BDE-47 (left) and BDE-153 (right) (ng/g lipid) by age and year of collection (log scale).
Fig. 2. Concentrations of sum HBCDD (left) and α and y-HBCDD (right) (log scale).
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Fig. 3. Concentrations of BDE-47 and -153 (ng/g lipid) for 0–4 year olds in 2002/3 (n=4), 2004/5 (n=4), 2006/7 (n=32), 2008/9 (n= 4), 2010/11 (n=4),
2012/13 (n= 4) and 2014/15 (=32); Box and whisker represents mean and minimum to maximum.
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et al., 2018).
3.1. Demographic trends of PBDEs and HBCDDs in Australian children
A positive association was found between BDE-47 levels and age
(R=0.41, p=0.008) in serum from Australian children collected in
this study (Fig. 1). However, there was no observed trend between age
and concentration of BDE-99 (R=0.059, p=0.72), or BDE-153
(R=−0.021, p=0.893). While not statistically signiﬁcant, the total
proportion of BDE-153 to total PBDE content was highest in children
under 2 years (R=0.288, p=0.074). This, combined with the positive
association of BDE-47 levels and age could suggest that more recently
born infants are exposed to more historical PBDEs via breastmilk. This
is because BDE-153 has a longer half-life in humans than other PBDEs,
such as BDEs −47 and− 99 (Geyer et al., 2004). Therefore a mother
who has had an historical exposure to PBDEs is likely to display a
higher BDE-153:ΣPBDEs ratio than one who has had a more recent
exposure. This would in turn be passed on to an infant via placental
transfer and breastfeeding and subsequently displayed in their serum
concentrations. In contrast, BDE-47 may have been excreted more ra-
pidly, therefore lowering mothers' body burdens and subsequently re-
ducing placental transfer and exposure via breastmilk. In similar pools
collected in 2006/7, the reverse of this trend was observed with the
contribution of BDE-153 towards ∑PBDEs increasing with age of chil-
dren (Toms et al., 2009).
Pools were also tested for any gender diﬀerences in PBDE levels.
However there were no signiﬁcant diﬀerences (t-test) between con-
centration and gender for BDE-47 (p=0.42), BDE-99 (p=0.59) or
BDE-153 (p=0.34) with the highest concentrations observed in pools
from the females 30–36months (26 ng/g lipid) and males 6–12months
(21 ng/g lipid) categories.
The median ∑HBCDD concentration in this study (0.48 ng/g lipid) is
comparable with that of 4 pooled samples collected from Australian
children 0–4 year olds in 2013 at 0.35 ng/g lipid (Drage et al., 2017).
No statistically signiﬁcant trends were observed between ΣHBCDD and
age (R2= 0.098, p=0.55, Fig. 2) or gender (t-test, p=0.74). The
dominance of α-HBCDD in this study is consistent with previous studies
from Australia (Toms et al., 2012; Drage et al., 2017) as well as serum
from India (Devanathan et al., 2012), Sweden (Weiss et al., 2006),
Canada (Rawn et al., 2014) and Japan (Kakimoto et al., 2008). Selective
predominance of α-HBCDD in biota has been previously reported
(Tomy et al., 2004, Law et al., 2006).
3.2. Temporal trends of PBDEs in serum from Australian children
For ∑4PBDEs a signiﬁcant decrease of> 85% was seen for children
aged 0–4 years between 2006/07 (mean=40 ng/g lipid) and 2014/15
(mean=5.6 ng/g lipid) in Australia (Fig. 3) (Mann-Whitney test
p < 0.0001). The p-values for each Mann-Whitney test conducted be-
tween 2014/15 and previous sampling campaigns are presented for
BDEs−47 and−153 in the supporting information (Tables S2 and S3).
These data demonstrate that PBDE levels in Australian children have
undergone a dramatic year-on-year decrease consistently since their
bans in Australia. This diﬀers to the patterns observed in adults where a
less prominent decrease of approximately 55% was observed for BDE-
47 (mean decrease from 8.3 ng/g lipid (2006/7) to 3.6 ng/g lipid
(2012/13) all pools from aged> 16 years) and a lower decrease in
BDE-153 by approximately 22% (mean of> 16 years 3.6 and 2.8 ng/g
lipid for 2006/07 and 2012/13, respectively) (Toms et al., 2018). This
change may be related to decrease or removal of a source of exposure.
Previous studies have indicated diﬀerences in adult and child exposure
with regards to dust ingestion, mouthing/child-speciﬁc behaviours such
as eating with ﬁngers, and breast milk consumption (Toms et al., 2015;
Heﬀernan et al., 2016; Jones-Otazo et al., 2005; Lorber, 2008; Stapleton
et al., 2005; Harrad et al., 2008). Adult concentrations have decreased
only slightly over the 10 year period. This diﬀerence between adults
and children could also be related to growth and therefore a faster rate
of dilution in children compared to adults. PBDE concentrations in fe-
males of child-bearing age have not changed over this same time period
(Toms et al., 2018), however, if major external sources of PBDEs are
being removed from microenvironments (i.e. replaced with “PBDE-free
products”, then these initial exposures via breastfeeding and placental
transfer are likely to be quickly diluted as a child grows rapidly in the
ﬁrst few years of life.
With the apparent reduction of exposure to PBDEs for children
potentially via indoor dust and child-speciﬁc behaviours, it is likely that
traditional sources, i.e. placental transfer (Zhao et al., 2013), breast
milk (Toms et al., 2007) and food (Domingo, 2012) will provide greater
contribution to future paediatric PBDE exposure.
4. Conclusions
There has been a signiﬁcant reduction in PBDE concentration in
Australian children over the decade following the bans of commercial
Penta-BDE and Octa-BDE in 2005. HBCDD concentrations were sub-
stantially lower than PBDEs but continued monitoring is required to
assess temporal trends. Previous observations that PBDE concentrations
are much higher in young children than in adults are no longer ap-
parent. This decrease in PBDE concentrations appears to be rapid
compared to adult PBDE concentrations over the same period. This is
likely to be due to a reduction in the number of PBDE-containing pro-
ducts in indoor microenvironments as they have been disposed and
replaced with “PBDE-free” alternatives. Subsequent assessments of the
youngest age groups are predicted to show concentrations similar to
maternal concentrations. If this pattern continues in future monitoring
programmes in Australia, it would suggest a change in the relative
sources of exposure. This means that similar to “traditional” POPs,
placental transfer, human milk, and general exposures in the food
supply, will become the major sources of PBDE exposure for infants and
young children, and that indoor environments will make a lower con-
tribution to overall concentrations.
Acknowledgements
All laboratory staﬀ are gratefully acknowledged for their assistance
and provision of sample pools. Queensland Alliance for Environmental
Sciences is co-funded by Queensland Health. This project was partly
funded by The Financial Markets Foundation for Children.
Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.envint.2018.11.044.
References
Ali, N., Eqani, S.A.M.A.S., Malik, R.N., Neels, H., Covaci, A., 2003. Organohalogenated
contaminants (OHCs) in human serum of mothers and children from Pakistan with
urban and rural residential settings. Sci. Total Environ. 461–462, 655–662.
Athanasiadou, M., Cuadra, S.N., Marsh, G., Bergman, A., Jakobsson, K., 2008.
Polybrominated diphenyl ethers (PBDEs) and bioaccumulative hydroxylated PBDE
metabolites in young humans from Managua, Nicaragua. Environ. Health Perspect.
116, 400–408.
Chemical Watch, 2017. POPs Convention set to ban two more Substances: DecaBDE and
Short-chain Chlorinated Paraﬃns Poised for Listing [Online]. Available. https://
chemicalwatch.com/55636/pops-convention-set-to-ban-two-more-substances
(Accessed 7 June 2017).
Costa, L.G., Giordano, G., Tagliaferri, S., Caglieri, A., Mutti, A., 2008. Polybrominated
diphenyl ether (PBDE) ﬂame retardants: environmental contamination, human body
burden and potential adverse health eﬀects. Acta Biomed 79, 172–183.
Devanathan, G., Subramanian, A., Sudaryanto, A., Takahashi, S., Isobe, T., Tanabe, S.,
2012. Brominated ﬂame retardants and polychlorinated biphenyls in human breast
milk from several locations in India: potential contaminant sources in a municipal
dumping site. Environ. Int. 39, 87–95.
Domingo, J.L., 2012. Polybrominated diphenyl ethers in food and human dietary ex-
posure: a review of the recent scientiﬁc literature. Food Chem. Toxicol. 50, 238–249.
D.S. Drage et al. Environment International 122 (2019) 363–368
367
Dorosh, A., Ded, L., Elzeinova, F., Peknicova, J., 2011. Assessing oestrogenic eﬀects of
brominated ﬂame retardants hexabromocyclododecane and tetrabromobisphenol A
on MCF-7 cells. Folia Biol. (Praha) 57, 35–39.
Drage, D., Mueller, J.F., Birch, G., Eaglesham, G., Hearn, L.K., Harrad, S., 2015. Historical
trends of PBDEs and HBCDs in sediment cores from Sydney estuary, Australia. Sci.
Total Environ. 512–513, 177–184.
Drage, D.S., Mueller, J.F., Hobson, P.L., Harden, F.A., Toms, L.-M.L., 2017. Demographic
and temporal trends of hexabromocyclododecanes (HBCDD) in an Australian popu-
lation. Environ. Res. 152, 192–198.
Drage, D.S., Sharkey, M., Abdallah, M.A., Berresheim, H., Harrad, S., 2018. Brominated
ﬂame retardants in Irish waste polymers: concentrations, legislative compliance, and
treatment options. Sci. Total Environ. 625, 1535–1543.
Eskenazi, B., Fenster, L., Castorina, R., Marks, A.R., Sjodin, A., Rosas, L.G., Holland, N.,
Guerra, A.G., Lopez-Carillo, L., Bradman, A., 2011. A comparison of PBDE serum
concentrations in Mexican and Mexican-American children living in California.
Environ. Health Perspect. 119, 1442–1448.
European Chemicals Agency, 2009. Background Document for Hexabromocyclododecane
and all Major Diastereoisomers Identiﬁed (HBCDD) [Online]. Available: https://
echa.europa.eu/documents/10162/13640/hbcdd_en.pdf (Accessed 03 April 2017).
European Chemicals Bureau, 2000. In: PROTECTION, I. F. H. A. C (Ed.), European Union
Risk Assessment Report, Diphenyl Ether, Pentabromo Derivative
(Pentabromodiphenylether).
European Commission, 2011. Final Report: Study on Waste Related Issues of Newly Listed
POPs and Candidate POPs. [Online]. Available: http://ec.europa.eu/environment/
waste/studies/pops.htm, Accessed date: 5 March 2017.
Fernandes, A., White, S., D'Silva, K., Rose, M., 2004. Simultaneous determination of
PCDDs, PCDFs, PCBs and PBDEs in food. Talanta 64, 1147–1155.
Gari, M., Grimalt, J.O., 2013. Inverse age-dependent accumulation of decabromodiphenyl
ether and other PBDEs in serum from a general adult population. Environ. Int. 54,
119–127.
Genskow, K.R., Bradner, J.M., Hossain, M.M., Richardson, J.R., Caudle, W.M., 2015.
Selective damage to dopaminergic transporters following exposure to the brominated
ﬂame retardant, HBCDD. Neurotoxicol. Teratol. 52 (Part B), 162–169.
Geyer, H.J., Schramm, K., Darnerud, P.O., Aune, M., Feicht, E.A., Fried, K.W.,
Henkelmann, B., Lenoir, D., Schmid, P., McDonald, T.A., 2004. Terminal elimination
half-lives of the brominated ﬂame retardants TBBPA, HBCD, and lower brominated
PBDEs in humans. Organohalogen Compd. 66, 3820–3825.
Grandjean, P., Landrigan, P.L., 2014. Neurobehavioural eﬀects of developmental toxicity.
Lancet. https://doi.org/10.1016/S1474-4422(13)70278-3.
Harrad, S., Ibarra, C., Diamond, M., Melymuk, L., Robson, M., Douwes, J., Roosens, L.,
Dirtu, A.C., Covaci, A., 2008. Polybrominated diphenyl ethers in domestic indoor
dust from Canada, New Zealand, United Kingdom and United States. Environ. Int. 34,
232.
He, C., Wang, X., Thai, P., Baduel, C., Gallen, C., Banks, A., Bainton, P., English, K.,
Mueller, J.F., 2018. Organophosphate and brominated ﬂame retardants in Australian
indoor environments: levels, sources, and preliminary assessment of human exposure.
Environ. Pollut. 235, 670–679.
Health and Environment Alliance, 2013. Global ban of Flame Retardant HBCD. http://
www.env-health.org/news/latest-news/article/global-ban-of-ﬂame-retardant-hbcd
(accessed 6.6.14).
Heﬀernan, A.L., Aylward, L.L., Toms, L.-M.L., Sly, P.D., Macleod, M., Mueller, J.F., 2014.
Pooled biological specimens for human biomonitoring of environmental chemicals:
opportunities and limitations. J. Expo. Sci. Environ. Epidemiol. 24 (3), 225–232.
Heﬀernan, A., English, K., Toms, L., Calafat, A., Valentin-Blasini, L., Hobson, P.,
Broomhall, S., Ware, R., Jagals, P., Sly, P., Mueller, J., 2016. Cross-sectional bio-
monitoring study of pesticide exposures in Queensland, Australia, using pooled urine
samples. Environ. Sci. Pollut. Res. 1–13.
Hurley, S., Goldberg, D., Nelson, D.O., Guo, W., Wang, Y., Baek, H.G., Park, J.S., Petreas,
M., Bernstein, L., Anton-Culver, H., Reynolds, P., 2017. Temporal evaluation of
polybrominated diphenyl ether (PBDE) serum levels in middle-aged and older
California women, 2011–2015. Environ. Sci. Technol. 51 (8), 4697–4704.
Jones-Otazo, H.A., Clarke, J.P., Diamond, M.L., Archbold, J.A., Ferguson, G., Harner, T.,
Richardson, G.M., Ryan, J.J., Wilford, B., 2005. Is house dust the missing exposure
pathway for PBDEs? An analysis of the urban fate and human exposure to PBDEs.
Environ. Sci. Technol. 39, 5121–5130. https://doi.org/10.1021/es048267b.
Kakimoto, K., Akutsu, K., Konishi, Y., Tanaka, Y., 2008. Time trend of hex-
abromocyclododecane in the breast milk of Japanese women. Chemosphere 71,
1110–1114.
Law, R.J., Allchin, C.R., de Boer, J., Covaci, A., Herzke, D., Lepom, P., Morris, S.,
Tronczynski, J., de Wit, C.A., 2006. Levels and trends of brominated ﬂame retardants
in the European environment. Chemosphere 64, 187–208.
Lorber, M., 2008. Exposure of Americans to polybrominated diphenyl ethers. J. Expo. Sci.
Environ. Epidemiol. 18, 2–19.
Ma, Y., Li, P., Jin, J., Wang, Y., Wang, Q., 2017. Current halogenated ﬂame retardant
concentrations in serum from residents of Shandong Province, China, and temporal
changes in the concentrations. Environ. Res. 155, 116–122.
Maurice, N., Olry, J.-C., Cariou, R., Dervilly-Pinel, G., Le Bizec, B., Travel, A., Jondreville,
C., Schroeder, H., 2015. Short-term eﬀects of a perinatal exposure to the HBCDD α-
isomer in rats: assessment of early motor and sensory development, spontaneous
locomotor activity and anxiety in pups. Neurotoxicol. Teratol. 52, 170–180.
Meeker, J.D., Johnson, P.I., Camann, D., Hauser, R., 2009. Polybrominated diphenyl ether
(PBDE) concentrations in house dust are related to hormone levels in men. Sci. Total
Environ. 407, 3425–3429.
NICNAS, 2007. Interim Public Health Risk Assessment Report on Certain PBDE Congeners
Contained in Commercial Preparations of Pentabromodiphenyl Ether and
Octabromodiphenyl Ether. http://www.nicnas.gov.au/Publications/CAR/Other/
PBDE_PDF.pdf.
Parry, E., Zota, A.R., Park, J.S., Woodruﬀ, T.J., 2018. Polybrominated diphenyl ethers
(PBDEs) and hydroxylated PBDE metabolites (OH-PBDEs): a six-year temporal trend
in northern California pregnant women. Chemosphere 195, 777–783.
Pérez-Maldonado, I.N., Ramírez-Jiménez, M. del R., Martínez-Arévalo, L.P., López-
Guzmán, O.D., Athanasiadou, M., Bergman, Å., Yarto-Ramírez, M., Gavilán-García,
A., Yáñez, L., Díaz-Barriga, F., 2009. Exposure assessment of polybrominated di-
phenyl ethers (PBDEs) in Mexican children. Chemosphere 75, 1215–1220.
Phillips, D., Pirkle, J., Burse, V., Bernert, J., Henderson, L.O., Needham, L., 1989.
Chlorinated hydrocarbon levels in human serum: eﬀects of fasting and feeding. Arch.
Environ. Contam. Toxicol. 18, 495–500.
Rawn, D.F.K., Ryan, J.J., Sadler, A.R., Sun, W.-F., Weber, D., Laﬀey, P., Haines, D.,
Macey, K., van Oostdam, J., 2014. Brominated ﬂame retardant concentrations in sera
from the Canadian Health Measures Survey (CHMS) from 2007 to 2009. Environ. Int.
63, 26–34.
Stapleton, H.M., Dodder, N.G., Oﬀenberg, J.H., Schantz, M.M., Wise, S.A., 2005.
Polybrominated diphenyl ethers in house dust and clothes dryer lint. Environ. Sci.
Technol. 39, 925–931.
Stapleton, H.M., Eagle, S., Sjodin, A., Webster, T.F., 2012. Serum PBDEs in a North
Carolina toddler cohort: associations with handwipes, house dust, and socioeconomic
variables. Environ. Health Perspect. 120, 1049–1054.
Stockholm Convention, 2009. The 9 new POPs [WWW Document]. http://chm.pops.int/
Programmes/NewPOPs/The9newPOPs/tabid/672/language/en-US/Default.aspx,
Accessed date: 11 January 2010.
Thomas, A., Toms, L.M.L., Harden, F.A., Hobson, P., White, N.M., Mengersen, K.L.,
Mueller, J.F., 2017. Concentrations of organochlorine pesticides in pooled human
serum by age and gender. Environ. Res. 154, 10–18.
Toms, L.-M.L., Harden, F.A., Symons, R.K., Burniston, D., Fürst, P., Müller, J.F., 2007.
Polybrominated diphenyl ethers (PBDEs) in human milk from Australia.
Chemosphere 68, 797–803.
Toms, L.M.L., Harden, F., Paepke, O., Hobson, P., Ryan, J.J., Mueller, J.F., 2008. Higher
accumulation of polybrominated diphenyl ethers (PBDEs) in infants than in adults.
Environ. Sci. Technol. 42 (19), 7510–7515.
Toms, L.L., Sjodin, A., Harden, F., Hobson, P., Jones, R., Edenﬁeld, E., Mueller, J.F., 2009.
Serum Polybrominated diphenyl ether (PBDE) levels are higher in children (2–5 years
of age) than in infants and adults. Environ. Health Perspect. 117, 1461–1465.
Toms, L.-M.L., Guerra, P., Eljarrat, E., Barceló, D., Harden, F.A., Hobson, P., Sjodin, A.,
Ryan, E., Mueller, J.F., 2012. Brominated ﬂame retardants in the Australian popu-
lation: 1993–2009. Chemosphere 89, 398–403.
Toms, L.M., Thompson, J., Rotander, A., Hobson, P., Calafat, A.M., Kato, K., Ye, X.,
Broomhall, S., Harden, F., Mueller, J.F., 2014. Decline in perﬂuorooctane sulfonate
and perﬂuorooctanoate serum concentrations in an Australian population from 2002
to 2011. Environ. Int. 71, 74–80.
Toms, L.-M.L., Mazaheri, M., Brommer, S., Cliﬀord, S., Drage, D., Mueller, J.F., Thai, P.,
Harrad, S., Morawska, L., Harden, F.A., 2015. Polybrominated diphenyl ethers
(PBDEs) in dust from primary schools in South East Queensland, Australia. Environ.
Res. 142, 135–140.
Toms, L., Sjödin, A., Hobson, P., Harden, F., Aylward, L., Mueller, J., 2018. Temporal
trends in serum polybrominated diphenyl ether concentrations in the Australian
population, 2002–2013. Environ. Int. 19, 357–364.
Tomy, G.T., Budakowski, W., Halldorson, T., Whittle, D.M., Keir, M.J., Marvin, C.,
MacInnis, G., Alaee, M., 2004. Biomagniﬁcation of α- and γ-hex-
abromocyclododecane isomers in a Lake Ontario food web. Environ. Sci. Technol. 38,
2298–2303.
United Nations Environment Programme (UNEP), 2010. Technical review of the im-
plications of recycling commercial Penta and Octabromodiphenyl ethers. In:
Stockholm Convention Document for 6th POP Reviewing Committee Meeting
(UNEP/POPS/POPRC.6/2), [Online]. Available: http://chm.pops.int/Portals/0/
Repository/POPRC6/UNEP-POPS-POPRC.6-2.English.pdf, Accessed date: 5 April
2017.
Wang, X., Thai, P.K., Mallet, M., Desservettaz, M., Hawker, D.W., Keywood, M., Miljevic,
B., Paton-Walsh, C., Gallen, M., Mueller, J.F., 2017. Emissions of selected semi-
volatile organic chemicals from forest and savannah ﬁres. Environ. Sci. Technol. 51,
1293–1302.
Weiss, J., Wallin, E., Axmon, A., Jönsson, B.A.G., Åkesson, H., Janák, K., Hagmar, L.,
Bergman, Å., 2006. Hydroxy-PCBs, PBDEs, and HBCDDs in serum from an elderly
population of Swedish ﬁshermen's wives and associations with bone density. Environ.
Sci. Technol. 40, 6282–6289.
Zhang, L., Yin, S., Zhao, Y., Shi, Z., Li, J., Wu, Y., 2017. Polybrominated diphenyl ethers
and indicator polychlorinated biphenyls in human milk from China under the
Stockholm convention. Chemosphere 189, 32–38.
Zhao, Y., Ruan, X., Li, Y., Yan, M., Qin, Z., 2013. Polybrominated diphenyl ethers (PBDEs)
in aborted human fetuses and placental transfer during the ﬁrst trimester of preg-
nancy. Environ. Sci. Technol. 47, 5939–5946.
D.S. Drage et al. Environment International 122 (2019) 363–368
368
